Brief: Akari Therapeutics Regains Full Nasdaq Compliance

Akari Therapeutics

19/11/2024 13:20

Nov 19 (Reuters) - Akari Therapeutics PLC  AKTX.O :
    * AKARI THERAPEUTICS REGAINS FULL NASDAQ COMPLIANCE
    * AKARI THERAPEUTICS PLC - NASDAQ HEARING FOR AKARI
THERAPEUTICS
ON NOVEMBER 21 CANCELLED

Source text:  ID:nGNX109G1z 
Further company coverage:  AKTX.O 

 ((Reuters.Briefs@thomsonreuters.com;))